Pork during Pandemics: Federal Spending and Public Health Crises

2020 ◽  
Vol 1 (4) ◽  
pp. 507-521
Author(s):  
Nicholas G. Napolio
Author(s):  
Michael Kinch

Despite and arguably because of the enormous public health benefits arising from the introduction of new medicines, the industry is in the midst of crisis. We detail in this chapter the decline in research and development efficiency, which has been termed “Eroom's Law,” a playful inversion of the bettern known Moore's Law of Computing. An explanation of declining efficiency follows as is a brief summary of some remedies taken by many biopharmaceutical entities, including the abandonment of therapeutics targeting particularly difficult indications such as Alzheimer's disease and antibiotics. We also convey how the industry has developed into a sort of food chain, with smaller companies and government grants supporting the earliest stages of research, which are then acquired by medium-sized companies, which in turn are consolidated into large companies. This food chain is fundamentally in doubt based on shrinking Federal spending on research combined with a decline in venture capital support for early-stage start-ups.


1997 ◽  
Vol 6 (1) ◽  
pp. 11-16
Author(s):  
Terrey Oliver Penn ◽  
Susan E. Abbott

2001 ◽  
Vol 9 (6) ◽  
pp. 507-509 ◽  
Author(s):  
Rob Baggott ◽  
David J Hunter

Sign in / Sign up

Export Citation Format

Share Document